AbbVie sees strong 2022 earnings as Botox, Skyrizi power profit beat

Go back to AbbVie sees strong 2022 earnings as Botox, Skyrizi power profit beat
AbbVie (NYSE: ABBV) Delayed: 249.37 +0.59 (0.24%)
Previous Close $248.78    52 Week High $68.12 
Open $247.73    52 Week Low $50.71 
Day High $250.96    P/E 54.09 
Day Low $246.77    EPS $4.61 
Volume 1,221,949